Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2015, Article ID 840594, 11 pages
http://dx.doi.org/10.1155/2015/840594
Research Article

Radiosensitizing and Hyperthermic Properties of Hyaluronan Conjugated, Dextran-Coated Ferric Oxide Nanoparticles: Implications for Cancer Stem Cell Therapy

1Department of Radiation Oncology, Beaumont Health System, Royal Oak, MI 48073, USA
2Department of Physics, Oakland University, Rochester, MI 48309, USA
3Department of Chemistry, Michigan State University, East Lansing, MI 48824, USA

Received 19 August 2015; Accepted 19 November 2015

Academic Editor: Piaoping Yang

Copyright © 2015 Ranjeeta Thapa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Vermorken, E. Remenar, C. van Herpen et al., “Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer,” The New England Journal of Medicine, vol. 357, no. 17, pp. 1695–1704, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. C. Tremmel, K. Götte, S. Popp et al., “Intratumoral genomic heterogeneity in advanced head and neck cancer detected by comparative genomic hybridization,” Cancer Genetics and Cytogenetics, vol. 144, no. 2, pp. 165–174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Bryne, M. Boysen, C. G. Alfsen et al., “The invasive front of carcinomas. the most important area for tumour prognosis?” Anticancer Research, vol. 18, no. 6, pp. 4757–4764, 1998. View at Google Scholar · View at Scopus
  4. T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, “Stem cells, cancer, and cancer stem cells,” Nature, vol. 414, no. 6859, pp. 105–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. E. Prince, R. Sivanandan, A. Kaczorowski et al., “Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 3, pp. 973–978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, “Prospective identification of tumorigenic breast cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983–3988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Davis, V. Divi, J. H. Owen et al., “Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma,” Archives of Otolaryngology—Head & Neck Surgery, vol. 136, no. 12, pp. 1260–1266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. C. de Jong, J. Pramana, J. E. van der Wal et al., “CD44 expression predicts local recurrence after radiotherapy in larynx cancer,” Clinical Cancer Research, vol. 16, no. 21, pp. 5329–5338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kajita, Y. Itoh, T. Chiba et al., “Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration,” Journal of Cell Biology, vol. 153, no. 5, pp. 893–904, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. Isacke and H. Yarwood, “The hyaluronan receptor, CD44,” International Journal of Biochemistry & Cell Biology, vol. 34, no. 7, pp. 718–721, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. H. El-Dakdouki, D. C. Zhu, K. El-Boubbou et al., “Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells,” Biomacromolecules, vol. 13, no. 4, pp. 1144–1151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. V. M. Plattt and F. C. Szoka Jr., “Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor,” Molecular Pharmaceutics, vol. 5, no. 4, pp. 474–486, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. T. C. Laurent, U. B. G. Laurent, and J. R. E. Fraser, “The structure and function of hyaluronan: an overview,” Immunology and Cell Biology, vol. 74, no. 2, pp. A1–A7, 1996. View at Google Scholar · View at Scopus
  14. A. Bartolazzi, R. Peach, A. Aruffo, and I. Stamenkovic, “Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development,” Journal of Experimental Medicine, vol. 180, no. 1, pp. 53–66, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. D. A. Gewirtz, M. L. Bristol, and J. C. Yalowich, “Toxicity issues in cancer drug development,” Current Opinion in Investigational Drugs, vol. 11, no. 6, pp. 612–614, 2010. View at Google Scholar · View at Scopus
  16. R. Pérez-Tomás, “Multidrug resistance: retrospect and prospects in anti-cancer drug treatment,” Current Medicinal Chemistry, vol. 13, no. 16, pp. 1859–1876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. M. Gottesman, T. Fojo, and S. E. Bates, “Multidrug resistance in cancer: role of ATP-dependent transporters,” Nature Reviews Cancer, vol. 2, no. 1, pp. 48–58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Gottesman and V. Ling, “The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research,” FEBS Letters, vol. 580, no. 4, pp. 998–1009, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Frank, C. Tyagi, L. Tomar et al., “Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 589–613, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. H. El-Dakdouki, K. El-Boubbou, D. C. Zhu, and X. Huang, “A simple method for the synthesis of hyaluronic acid coated magnetic nanoparticles for highly efficient cell labelling and in vivo imaging,” RSC Advances, vol. 1, no. 8, pp. 1449–1452, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Kong, J. Zeng, X. P. Wang et al., “Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles,” Small, vol. 4, no. 9, pp. 1537–1543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. Hainfeld, D. N. Slatkin, and H. M. Smilowitz, “The use of gold nanoparticles to enhance radiotherapy in mice,” Physics in Medicine and Biology, vol. 49, no. 18, pp. N309–N315, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. F.-K. Huang, W.-C. Chen, S.-F. Lai et al., “Enhancement of irradiation effects on cancer cells by cross-linked dextran-coated iron oxide (CLIO) nanoparticles,” Physics in Medicine and Biology, vol. 55, no. 2, pp. 469–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Verma, S. Lal, and C. J. F. Van Noorden, “Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 2863–2877, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Kamat, K. El-Boubbou, D. C. Zhu et al., “Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages,” Bioconjugate Chemistry, vol. 21, no. 11, pp. 2128–2135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. K. El-Boubbou, D. C. Zhu, C. Vasileiou et al., “Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging,” Journal of the American Chemical Society, vol. 132, no. 12, pp. 4490–4499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Trapasso and E. Allegra, “Role of CD44 as a marker of cancer stem cells in head and neck cancer,” Biologics, vol. 6, pp. 379–383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. D. M. Herold, I. J. Das, C. C. Stobbe, R. V. Iyer, and J. D. Chapman, “Gold microspheres: a selective technique for producing biologically effective dose enhancement,” International Journal of Radiation Biology, vol. 76, no. 10, pp. 1357–1364, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. J. C. Roeske, L. Nuñez, M. Hoggarth, E. Labay, and R. R. Weichselbaum, “Characterization of the theorectical radiation dose enhancement from nanoparticles,” Technology in Cancer Research and Treatment, vol. 6, no. 5, pp. 395–401, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Huang, H. Chen, Y. Dong et al., “Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy,” Theranostics, vol. 3, no. 2, pp. 116–126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Klein, A. Sommer, L. V. R. Distel, W. Neuhuber, and C. Kryschi, “Superparamagnetic iron oxide nanoparticles as radiosensitizer via enhanced reactive oxygen species formation,” Biochemical and Biophysical Research Communications, vol. 425, no. 2, pp. 393–397, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. H. El-Dakdouki, E. Puré, and X. Huang, “Development of drug loaded nanoparticles for tumor targeting. Part 2: enhancement of tumor penetration through receptor mediated transcytosis in 3D tumor models,” Nanoscale, vol. 5, no. 9, pp. 3904–3911, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. H. El-Dakdouki, K. El-Boubbou, M. Kamat et al., “CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging,” Pharmaceutical Research, vol. 31, no. 6, pp. 1426–1437, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Dutz and R. Hergt, “Magnetic particle hyperthermia—a promising tumour therapy?” Nanotechnology, vol. 25, no. 45, Article ID 452001, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Dutz and R. Hergt, “Magnetic nanoparticle heating and heat transfer on a microscale: basic principles, realities and physical limitations of hyperthermia for tumour therapy,” International Journal of Hyperthermia, vol. 29, no. 8, pp. 790–800, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. C. L. Dennis and R. Ivkov, “Physics of heat generation using magnetic nanoparticles for hyperthermia,” International Journal of Hyperthermia, vol. 29, no. 8, pp. 715–729, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Wabler, W. Zhu, M. Hedayati et al., “Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content,” International Journal of Hyperthermia, vol. 30, no. 3, pp. 192–200, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. Q. Zhao, L. Wang, R. Cheng et al., “Magnetic nanoparticle-based hyperthermia for head & neck cancer in mouse models,” Theranostics, vol. 2, no. 1, pp. 113–121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. G. F. Huber, A. Albinger-Hegyi, A. Soltermann et al., “Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma,” Cancer, vol. 117, no. 20, pp. 4659–4670, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. A. M. Baschnagel, L. Williams, A. Hanna et al., “C-met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation,” International Journal of Radiation Oncology Biology Physics, vol. 88, no. 3, pp. 701–707, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Li, P. Dong, C. Wu, P. Cao, and L. Zhou, “Notch1 overexpression associates with poor prognosis in human laryngeal squamous cell carcinoma,” Annals of Otology, Rhinology & Laryngology, vol. 123, no. 10, pp. 705–710, 2014. View at Publisher · View at Google Scholar
  42. C. Zhou and B. Sun, “The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis,” Oral Oncology, vol. 50, no. 12, pp. 1144–1148, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Schröck, M. Bode, F. J. M. Göke et al., “Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma,” Carcinogenesis, vol. 35, no. 7, pp. 1636–1642, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Krishnamurthy, Z. Dong, D. Vodopyanov et al., “Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells,” Cancer Research, vol. 70, no. 23, pp. 9969–9978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Chikamatsu, H. Ishii, G. Takahashi et al., “Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells,” Head and Neck, vol. 34, no. 3, pp. 336–343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Allegra, S. Trapasso, D. Pisani, and L. Puzzo, “The role of BMI1 as a biomarker of cancer stem cells in head and neck cancer: a review,” Oncology, vol. 86, no. 4, pp. 199–205, 2014. View at Publisher · View at Google Scholar · View at Scopus